Clinical Trial Update: Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of Eloralintide (LY3841136) for osteoarthritis knee pain in adults with overweight or obesity; currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Osteoarthritis

Drugs mentioned

• Eloralintide (LY3841136)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoarthritis, Overweight or Obesity | Phase 3 | Status: RECRUITING